DNA damage response in patients with pediatric Acute Lymphoid Leukemia during induction therapy

Júlia Plentz Portich1, Rafael Pereira Dos Santos2, Nathalia Kersting1

  • 1Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.

Leukemia Research
|January 23, 2017
PubMed

Insights

This study examined DNA damage and repair in pediatric Acute Lymphoid Leukemia (ALL) patients undergoing chemotherapy. While overall DNA damage didn't increase, changes in low-damage cells suggest repair mechanisms may influence treatment outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Predicting chemotherapy response is vital in cancer treatment.
  • Nucleotide Excision Repair (NER) pathways are implicated in DNA repair and cancer prognosis.
  • Limited research exists on DNA damage and repair in pediatric Acute Lymphoid Leukemia (ALL).

Purpose of the Study:

  • To investigate DNA damage and NER pathway gene expression in pediatric ALL patients during chemotherapy induction.
  • To explore the potential link between DNA damage, repair mechanisms, and clinical outcomes in pediatric ALL.

Main Methods:

  • An observational follow-up study involving 28 pediatric ALL patients.
  • Bone marrow samples collected at diagnosis, day 15 (D15), and day 35 (D35) of treatment.
  • Assessed DNA damage using the Comet Assay and analyzed NER pathway gene expression.

Main Results:

  • No significant increase in the overall DNA damage index was observed.
  • A reduction in cells with low DNA damage was noted by D35 compared to diagnosis.
  • NER pathway gene expression remained stable, with one patient showing a significant decrease, possibly due to pathway downregulation.

Conclusions:

  • DNA damage and repair dynamics in pediatric ALL bone marrow samples were analyzed for the first time.
  • Observed changes in DNA damage and repair may influence drug resistance and relapse risk.
  • Further monitoring of patient outcomes is needed to determine the implications for survival and relapse rates.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.3K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.3K
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
5.5K